Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Judson, Ian, Verweij, Jaap, Gelderblom, Hans, Hartmann, Jörg T, Schöffski, Patrick, Blay, Jean-Yves, Kerst, J Martijn, Sufliarsky, Josef, Whelan, Jeremy, Hohenberger, Peter, Krarup-Hansen, Anders, AlcVolume:
15
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(14)70063-4
Date:
April, 2014
File:
PDF, 320 KB
english, 2014